Personalizing Care with the Maine Cancer Genomics Initiative
The Maine Cancer Genomics Initiative stands out as part of our system-wide highly integrated cancer care delivery model. This initiative aims to provide the right care in the right location with advanced oncology services with sub-specialty skills and expertise.
Hospitals within the MaineHealth system are participating in this statewide initiative, led by the Jackson Laboratory in partnership with Maine Medical Center Research Institute (MMCRI) with generous support from the Harold Alfond Foundation. The goal is to enhance cancer diagnostics and treatment right here in Maine.
The Maine Genomics Initiative seeks to identify unique molecular level solutions to guide more personalized drug therapy for our patients. Participating hospitals recruit potentially eligible patients for clinical trials. Hospitals then guide the pathology team in developing diagnostic panels(s) of molecular tests to be performed at Maine Medical Center.
Launched June 2017, the study design of the Maine Cancer Genomics Initiative is to recruit participants through a network of 100 cancer care providers with a goal of reaching 600 Mane cancer patients within three years.
Study objectives include:
- Ongoing education of care providers with cutting edge research findings;
- Determining whether test results impacted care;
Conducting parallel educational program of oncologists; and
Monitoring patient’s perception of participation.
Long range opportunities for this project include:
- Improved patient outcomes;
Future access to other innovative clinical trial; and
- Positioning MaineHealth as a leader in personalized medicine.